Raymond James Financial
ASTH icon

Raymond James Financial’s Astrana Health ASTH Stock Holding History

Raymond James Financial’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$497 – 6859
2025
Q2 		$497 Buy
+20
New +$563 ﹤0.01% 6673

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Raymond James Financial's ASTH Position: Q3 2025 in Review

Raymond James Financial sold out of Astrana Health (ASTH) in Q3 2025, closing a stake of 20 shares — an estimated $497 sold.

Raymond James Financial first reported a position in ASTH in Q2 2025 and held it in 1 quarter. The position peaked at $497 in Q2 2025. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Raymond James Financial reported no remaining Astrana Health position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 20 Astrana Health shares in Q3 2025, an estimated $497.
  • Raymond James Financial first reported a position in Astrana Health in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Astrana Health position peaked at $497 in Q2 2025.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.